Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 3D chromatin reprogramming primes human memory TH2 cells for rapid recall and pathogenic dysfunction. | Sci Immunol | 2023 | 37418545 | PubTator, text mining | PubMed |
| Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease. | Front Cell Infect Microbiol | 2023 | 37415827 | PubTator, text mining | PubMed |
| IGH rod-like tracer: An AlphaFold2 structural similarity extraction-based predictive biomarker for MRD monitoring in pre-B-ALL. | iScience | 2023 | 37408685 | PubTator, text mining | PubMed |
| The Role of Regulatory T Cells in the Onset and Progression of Primary Sjögren's Syndrome. | Cells | 2023 | 37408193 | PubTator, text mining | PubMed |
| Fatal intracranial haemorrhage in acute promyelocytic leukemia patients with short isoform of PML-RARα: Review of molecular and radiological data. | Saudi J Biol Sci | 2023 | 37405260 | PubTator, text mining | PubMed |
| Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers. | Front Immunol | 2023 | 37398650 | PubTator, text mining | PubMed |
| Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma. | Genes Dis | 2023 | 37397559 | PubTator, text mining | PubMed |
| BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report. | Front Pharmacol | 2023 | 37397496 | PubTator, text mining | PubMed |
| Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance. | Mod Pathol | 2023 | 37391168 | PubTator, text mining | PubMed |
| The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL). | J Clin Exp Hematop | 2023 | 37380472 | PubTator, text mining | PubMed |
| Precursory or early lesions of follicular lymphoma: clinical features, pathology, and genetics. | J Clin Exp Hematop | 2023 | 37380471 | PubTator, text mining | PubMed |
| Pathophysiology of Rejection in Kidney Transplantation. | J Clin Med | 2023 | 37373823 | PubTator, text mining | PubMed |
| Evaluation of the Humoral and Cellular Immune Response Post COVID-19 Infection in Kidney Transplant Recipients. | J Clin Med | 2023 | 37373595 | PubTator, text mining | PubMed |
| Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications. | Biology (Basel) | 2023 | 37372147 | PubTator, text mining | PubMed |
| Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies. | Cells | 2023 | 37371081 | PubTator, text mining | PubMed |
| Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape. | Curr Oncol | 2023 | 37366925 | PubTator, text mining | PubMed |
| A nomogram for predicting the rapid progression of diffuse large B-cell lymphoma established by combining baseline PET/CT total metabolic tumor volume, lesion diffusion, and TP53 mutations. | Cancer Med | 2023 | 37366281 | PubTator, text mining | PubMed |
| [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37357002 | PubTator, text mining | PubMed |
| Variant-based heritability assessment of dexmedetomidine and fentanyl clearance in pediatric patients. | Clin Transl Sci | 2023 | 37353859 | PubTator, text mining | PubMed |
| Diagnostic Value and Prognosis Significance of Cerebrospinal Fluid Examination by Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia. | Technol Cancer Res Treat | 2023 | 37350078 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=15